Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
Preprint Article Version 1 This version is not peer-reviewed

Study Protocol for a Prospective Self-Controlled Trial on Success in Meeting Comprehensive Genomic Profiling Analysis Criteria for Specimens Obtained by Endoscopic Ultrasound-Guided Tissue Acquisition Using a 19G Needle from Primary and Metastatic Lesions

Version 1 : Received: 19 June 2024 / Approved: 20 June 2024 / Online: 20 June 2024 (13:14:56 CEST)

How to cite: Takeshita, K.; Hijioka, S.; Nagashio, Y.; Hara, H.; Agarie, D.; Kawasaki, Y.; Takasaki, T.; Yagi, S.; Hagiwara, Y.; Okamoto, K.; Yamashige, D.; Fukuda, S.; Kuwada, M.; Komori, Y.; Okada, M.; Maruki, Y.; Morizane, C.; Ueno, H.; Yatabe, Y.; Okusaka, T. Study Protocol for a Prospective Self-Controlled Trial on Success in Meeting Comprehensive Genomic Profiling Analysis Criteria for Specimens Obtained by Endoscopic Ultrasound-Guided Tissue Acquisition Using a 19G Needle from Primary and Metastatic Lesions. Preprints 2024, 2024061410. https://doi.org/10.20944/preprints202406.1410.v1 Takeshita, K.; Hijioka, S.; Nagashio, Y.; Hara, H.; Agarie, D.; Kawasaki, Y.; Takasaki, T.; Yagi, S.; Hagiwara, Y.; Okamoto, K.; Yamashige, D.; Fukuda, S.; Kuwada, M.; Komori, Y.; Okada, M.; Maruki, Y.; Morizane, C.; Ueno, H.; Yatabe, Y.; Okusaka, T. Study Protocol for a Prospective Self-Controlled Trial on Success in Meeting Comprehensive Genomic Profiling Analysis Criteria for Specimens Obtained by Endoscopic Ultrasound-Guided Tissue Acquisition Using a 19G Needle from Primary and Metastatic Lesions. Preprints 2024, 2024061410. https://doi.org/10.20944/preprints202406.1410.v1

Abstract

EUS–TA in unresectable pancreatic cancer requires not only a tissue diagnosis but also tissue collection in anticipation of comprehensive genomic profiling. However, the optimal puncture target remains controversial. Therefore, the Primary and Metastatic Lesions in Pancreatic Cancer (PRIMATE) study was designed to clarify the optimal target by comparing the success rates for meeting OncoGuide NCC Oncopanel (NOP) analysis criteria on pre-check primary and metastatic lesion specimens obtained during the same EUS–TA session in patients with invasive pancreatic ductal adenocarcinoma. In this ongoing prospective study, two specimens, each from primary and metastatic lesions, are obtained by EUS–TA (typically using a 19G fine-needle biopsy needle) in patients with invasive pancreatic ductal adenocarcinoma. The primary endpoint is the proportion of EUS–TA specimens that meet NOP analysis criteria during pre-check (i.e., tumor cellularity ≥ 20% and tissue area ≥ 4 mm2), which are then compared between primary and metastatic lesions. This study has been approved by the National Cancer Center Institutional Review Board (Research No. 2022-168). The results of this study will be reported at an international conference and published in an international peer-reviewed journal. The trial registration number is UMIN 000048966.

Keywords

endoscopic ultrasound-guided tissue acquisition; comprehensive genomic profiling; pancreatic cancer; metastatic lesion; fine-needle biopsy

Subject

Medicine and Pharmacology, Gastroenterology and Hepatology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.